Healthcare [ 7/13 ] | Medical Devices [ 107/159 ]
NYSE | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 2, 24 | 1.94 Increased by +2.65% | 1.87 Increased by +3.74% |
| Feb 8, 24 | 2.2 Increased by +17.02% | 2.15 Increased by +2.33% |
| Nov 7, 23 | 1.65 Increased by +4.43% | 1.6 Increased by +3.12% |
| Aug 1, 23 | 1.82 Increased by 0% | 1.81 Increased by +0.55% |
| May 2, 23 | 1.89 Increased by +17.39% | 1.64 Increased by +15.24% |
| Feb 3, 23 | 1.88 Decreased by -3.59% | 1.83 Increased by +2.73% |
| Nov 2, 22 | 1.58 Decreased by -12.71% | 1.56 Increased by +1.28% |
| Aug 2, 22 | 1.82 Decreased by -4.21% | 1.65 Increased by +10.3% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 1.94 B Increased by +6.3% | 419.2 M Increased by +421.97% | Increased by +21.61% Increased by +402.88% |
| Sep 30, 23 | 1.75 B Increased by +5.02% | 162.7 M Decreased by -16.13% | Increased by +9.28% Decreased by -20.14% |
| Jun 30, 23 | 1.87 B Increased by +4.93% | 209.6 M Increased by +36.37% | Increased by +11.21% Increased by +29.97% |
| Mar 31, 23 | 1.83 B Increased by +10.09% | 232.5 M Increased by +217.62% | Increased by +12.7% Increased by +188.51% |
| Dec 31, 22 | 1.83 B Increased by +2.7% | -130.2 M Decreased by -55% | Decreased by -7.13% Decreased by -50.93% |
| Sep 30, 22 | 1.67 B Decreased by -13.21% | 194 M Increased by +33.24% | Increased by +11.62% Increased by +53.53% |
| Jun 30, 22 | 1.78 B Decreased by -12.09% | 153.7 M Increased by +8.32% | Increased by +8.63% Increased by +23.22% |
| Mar 31, 22 | 1.66 B Decreased by -9.97% | 73.2 M Decreased by -63.05% | Increased by +4.4% Decreased by -58.96% |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.